U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07898774) titled 'To Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant Recipients' on Oct. 21.
Brief Summary: To assess the efficacy and safety of pegcetacoplan for the prevention of recurrent C3G or primary IC-MPGN in kidney transplant recipients
Study Start Date: Jan. 21, 2027
Study Type: INTERVENTIONAL
Condition:
C3 Glomerulopathy (C3G)
Primary Immune-Complex Membranoproliferative
Glomerulonephritis (IC-MPGN)
Kidney Transplantation
Recurrent Glomerular Disease After Kidney Transplantation
Intervention:
DRUG: Pegcetacoplan
Dose amount based on age and weight Subcutaneo...